Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

Affiliations

• ¹ Department of Gastroenterology, Ankara University, Ankara, and Department of Internal Medicine, Koc University, Istanbul, Turkey. Electronic address: [email protected].
• ² Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan.
• ³ Liver Unit, Hospital Universitario Vall d'Hebron and Ciber-ehd, Instituto Carlos III, Barcelona, Spain.
• ⁴ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
• ⁵ Institute of Gastroenterology and Liver Diseases Soroka University Medical Center Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba, Israel.
• ⁶ Auckland Clinical Studies, Auckland, New Zealand.
• ⁷ Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, Stanford, CA, USA.
• ⁸ Aga Khan University Hospital, Department of Medicine, Karachi, Pakistan.
• ⁹ Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
• ¹⁰ CRC "A. M. e A. Migliavacca", Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.
• ¹¹ Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Tel - Hashomer, 52621 Ramat Gan, Israel.
• ¹² Hepatology Centre of the University Hospital Professor Edgar Santos, Federal University of Bahia, Salvador, Brazil.
• ¹³ Department of Gastroenterology, University of Turin, Turin, Italy.
• ¹⁴ Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, Heidelberg, Germany.
• ¹⁵ Department of Gastroenterology and Hepatology, Essen University Hospital, University of Duisburg-Essen, Essen, Germany.